Telehealth company Hims & Hers is pushing the boundaries of drug compounding and testing the limits of regulators.
4don MSNOpinion
The Hims brand has primed people to view both their everyday health and the natural-aging processes as problems that can be ...
Hims has a great deal of meme potential, which could benefit the company by effectively acting as free advertising. Read more ...
Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...
Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.
During Sunday’s Super Bowl, Hims & Hers Health—a telehealth provider known for its provocative ads promoting erectile dysfunction and hair-loss treatments—aired a commercial portraying ...
2d
MarketBeat on MSNGLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss TrendsDetailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results